ROOT JONATHAN D sold 34.0% of their position (72.42K shares) of EFFECTOR THERAPEUTICS, INC. on the open market
Open‑market sale worth $475.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 6 sales
Filed: 12/1/2021ACC: 0001062993-21-011918
Director
Since Aug 2021
-72.42K
Net shares
Net seller
$475.4K
Total sold
6
Open market trades
0B · 6S
6
Total transactions
72.42K disposed
Non-Derivative Transactions6
Common Stock
Indirect
Shares
−24.96K
Price / share
$6.70
Trade value
$167.14K
% of position
0.6%
11/29/2021
4.46M→4.44M
Common Stock
Indirect
Shares
−799.00
Price / share
$6.70
Trade value
$5.35K
% of position
0.6%
11/29/2021
142.76K→141.96K
Common Stock
Indirect
Shares
−26.56K
Price / share
$6.53
Trade value
$173.48K
% of position
0.6%
11/30/2021
4.44M→4.41M
Common Stock
Indirect
Shares
−850.00
Price / share
$6.53
Trade value
$5.55K
% of position
0.6%
11/30/2021
141.96K→141.11K
Common Stock
Indirect
Shares
−18.65K
Price / share
$6.44
Trade value
$120.04K
% of position
0.4%
12/1/2021
4.41M→4.39M
Common Stock
Indirect
Shares
−597.00
Price / share
$6.44
Trade value
$3.84K
% of position
0.4%
12/1/2021
141.11K→140.51K
Total
Net shares
−72.42K
Net value
-$475.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/29/2021 | S · Sale | −24.96K | $6.70 | $167.14K | 0.6% | 4.46M | 4.44M |
| Common Stock Indirect | 11/29/2021 | S · Sale | −799.00 | $6.70 | $5.35K | 0.6% | 142.76K | 141.96K |
| Common Stock Indirect | 11/30/2021 | S · Sale | −26.56K | $6.53 | $173.48K | 0.6% | 4.44M | 4.41M |
| Common Stock Indirect | 11/30/2021 | S · Sale | −850.00 | $6.53 | $5.55K | 0.6% | 141.96K | 141.11K |
| Common Stock Indirect | 12/1/2021 | S · Sale | −18.65K | $6.44 | $120.04K | 0.4% | 4.41M | 4.39M |
| Common Stock Indirect | 12/1/2021 | S · Sale | −597.00 | $6.44 | $3.84K | 0.4% | 141.11K | 140.51K |
| Total | −72.42K | -$475.41K | ||||||
Derivative Transactions0
No derivative transactions reported